elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33798713-7C9B6455-FE20-4733-ACFB-749B9FF33CDD
Q33798713-7C9B6455-FE20-4733-ACFB-749B9FF33CDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33798713-7C9B6455-FE20-4733-ACFB-749B9FF33CDD
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.
P2860
Q33798713-7C9B6455-FE20-4733-ACFB-749B9FF33CDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33798713-7C9B6455-FE20-4733-ACFB-749B9FF33CDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
db55249d8fa6d79ebdf5433bb742593a291c0841
P2860
Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor.